External Source

Cs1003-305: Nofazinlimab And Lenvatinib In First-line Hcc

2025 2:36
Synopsis
Lorenza Rimassa, MD, Hunimed University, Milan, Italy, reviews the Phase III CS1003-305 study (NCT04194775) of nofazinlimab ...

You Might Also Like

CS1003-305: nofazinlimab and lenvatinib in first-line HCC 2:36
Cs1003-305: Nofazinlimab And Lenvatinib In First-line Hcc
2025
Lenvatinib remains standard of care for first-line therapy in advanced hepatocellular carcinoma 5:19
Lenvatinib Remains Standard Of Care For First-line Therapy I...
2022
Phase III Findings for Lenvatinib in HCC 1:24
Phase Iii Findings For Lenvatinib In Hcc
2017
Implication of Upfront Lenvatinib in HCC 8:55
Implication Of Upfront Lenvatinib In Hcc
2018
Frontline Lenvatinib vs Sorafenib in HCC 5:59
Frontline Lenvatinib Vs Sorafenib In Hcc
2017
Recent Drug Approvals: Lenvatinib Treatment of Unresectable Hepatocellular Carcinoma (HCC) 5:09
Recent Drug Approvals: Lenvatinib Treatment Of Unresectable ...
2024
LEAP-002: Lenvatinib Plus Pembrolizumab for First-Line Advanced HCC? 5:17
Leap-002: Lenvatinib Plus Pembrolizumab For First-line Advan...
2024
Lenvatinib As Up-front Therapy for Unresectable HCC 7:37
Lenvatinib As Up-front Therapy For Unresectable Hcc
2019
Upfront Lenvatinib in Unresectable HCC 6:54
Upfront Lenvatinib In Unresectable Hcc
2018
Dr. Finn on Significance of Phase III Findings of Lenvatinib in HCC 1:38
Dr. Finn On Significance Of Phase Iii Findings Of Lenvatinib...
2017
An Overview of Clinical Data from the REFLECT Trial for First-line Treatment of Unresectable HCC 21:00
An Overview Of Clinical Data From The Reflect Trial For Firs...
2025
HCC: Use of Lenvatinib and Sorafenib 6:51
Hcc: Use Of Lenvatinib And Sorafenib
2018
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.